Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara Sells 2,000 Shares

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the transaction, the chief executive officer now directly owns 101,735 shares in the company, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

Chemed Trading Up 0.3 %

NYSE CHE opened at $573.57 on Wednesday. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The firm’s fifty day simple moving average is $578.95 and its two-hundred day simple moving average is $564.99. The firm has a market capitalization of $8.63 billion, a P/E ratio of 28.98, a P/E/G ratio of 2.42 and a beta of 0.46.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter in the previous year, the firm posted $5.32 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. As a group, sell-side analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. Chemed’s payout ratio is currently 10.11%.

Wall Street Analyst Weigh In

CHE has been the topic of several research reports. StockNews.com lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Friday, November 22nd. Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.

Institutional Investors Weigh In On Chemed

Institutional investors and hedge funds have recently made changes to their positions in the stock. GAMMA Investing LLC lifted its position in Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust acquired a new position in Chemed during the third quarter valued at $61,000. Mather Group LLC. lifted its position in Chemed by 60.5% during the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after purchasing an additional 69 shares during the period. Quarry LP lifted its position in Chemed by 721.7% during the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares during the period. Finally, LRI Investments LLC acquired a new position in Chemed during the first quarter valued at $171,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.